Study of the heavy atom-induced room temperature phosphorescence properties of melatonin and its analytical application

Liquid phase room temperature phosphorescence (RTP) properties of melatonin were studied using heavy atom induced-room temperature phosphorescence (HAI-RTP) technique. 1.2 M potassium iodide was used as a heavy atom reagent together with 0.002 M sodium sulphite as deoxygenating agent to produce the RTP signal. The maximum phosphorescence emission and excitation wavelengths of melatonin were 290 and 457 nm, respectively. The effect of potassium iodide concentration on the RTP lifetime of melatonin was also investigated and based on the results, the rate constants for phosphorescence decay (k(p)) and radiationless deactivation through reaction with heavy atom (k(h)) were determined. Based on the obtained results, a simple and sensitive room temperature phosphorimetric method was developed for the determination of melatonin. The method allowed the determination of 10.0-200 ng ml(-1) melatonin in aqueous solution with the limits of detection and quantification of 3.6 and 12 ng ml(-1), respectively. The proposed method was satisfactorily applied to the determination of melatonin in commercial pharmaceutical formulations.     

Comparison of three different phosphorescent methodologies in solution for the analysis of naphazoline in pharmaceutical preparations

We present results from a comparative study of three proposed phosphorimetric methods for determination of naphazoline (NPZ) in solution. The first method is based on use of micelles to stabilize phosphorescence signals in solutions at room temperature (MS-RTP). The second is based on the use of a heavy atom salt and sodium sulfite as an oxygen scavenger to obtain room-temperature phosphorescence (HAI-RTP) in solution. The last method employs an optical sensor for NPZ based on the phosphorescent properties of the analyte on a solid sensor phase. The aim of this work was to compare time consumption, simplicity, sensitivity, selectivity, detection, and quantification limits for use of these three phosphorimetric methods to determine naphazoline in pharmaceutical preparations. The most simple, sensitive, and reproducible of the three methods for naphazoline analysis is the HAI-RTP method. Detection limits are 4.9, 1.7, and 9.4 ng mL^–1, respectively, for the MS-RTP, HAI-RTP, and optosensor methods.     

Determination of the amino acid tryptophan and the biogenic amine tryptamine in foods by the heavy atom induced-room temperature phosphorescence methodology

Very simple and selective methods are presented to determine the amino acid tryptophan (Trp) and the biogenic amine tryptamine (Tryp), both compounds with an indole-type molecular structure by the methodology named Heavy Atom Induced-Room Temperature Phosphorescence (HAI-RTP) which constitutes the first time that HAI-RTP has been used to detect compounds with non-naphthalenic structures in their molecules. Different variables affecting the phosphorescence signal (heavy atom perturber and sodium sulfite concentration) were carefully studied. The analytical curves give a linear dynamic range of 15-100 ng ml(-1) and a detection limit of 4 ng ml(-1) for Trp and 94-400 ng ml(-1) and 28 ng ml(-1) for Tryp. The methods have been successfully applied to the analysis of complex food matrices such as the presence of tryptophan in yoghurt and tryptamine in bottled beer. A single alkaline hydrolysis to release Trp from yoghurt proteins and two methods for extracting Tryp from beer samples are proposed and optimised. A total Trp content of 374 mg of Trp per kg of yoghurt was quantified by the standard addition method of calibration and a recovery of 90% was obtained for 250 ng ml(-1) of Tryp in spiked non-alcoholic beer samples.     

Determination of phenylpropanolamine and methoxamine using flow-injection with fluorimetric detection

A new flow-injection procedure for the determination of phenylpropanolamine and methoxamine is proposed. The method is based on the derivatization reaction of the primary amine group with o-phthalaldehyde in the presence of 2-mercaptoethanol using fluorimetric detection. The calibration graphs based on peak areas were linear in the ranges 5-200 ng ml(-1) for phenylpropanolamine and 0.2-6 ng ml(-1) for methoxamine. The detection limits were 3.8 and 0.13 ng ml(-1), respectively. The methods were applied to the determination of the drugs in commercial pharmaceutical preparations.     

Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations

Simple, rapid and highly sensitive spectrofluorimetric method is presented for the determination of four fluoroquinolone (FQ) drugs, ciprofloxacin, enoxacin, norfloxacin and moxifloxacin in pharmaceutical preparations. Proposed method is based on the derivatization of FQ with 4-chloro-7-nitrobenzofurazan (NBD-Cl) in borate buffer of pH 9.0 to yield a yellow product. The optimum experimental conditions have been studied carefully. Beer's law is obeyed over the concentration range of 23.5-500 ng mL(-1) for ciprofloxacin, 28.5-700 ng mL(-1) for enoxacin, 29.5-800 ng mL(-1) for norfloxacin and 33.5-1000 ng mL(-1) for moxifloxacin using NBD-Cl reagent, respectively. The detection limits were found to be 7.0 ng mL(-1) for ciprofloxacin, 8.5 ng mL(-1) for enoxacin, 9.2 ng mL(-1) for norfloxacin and 9.98 ng mL(-1) for moxifloxacin, respectively. Intra-day and inter-day relative standard deviation and relative mean error values at three different concentrations were determined. The low relative standard deviation values indicate good precision and high recovery values indicate accuracy of the proposed methods. The method is highly sensitive and specific. The results obtained are in good agreement with those obtained by the official and reference method. The results presented in this report show that the applied spectrofluorimetric method is acceptable for the determination of the four FQ in the pharmaceutical preparations. Common excipients used as additives in pharmaceutical preparations do not interfere with the proposed method.     

Multicommuted fluorometric multiparameter sensor for simultaneous determination of naproxen and salicylic acid in biological fluids.

A combined approach based on solid-phase optosensing and multicommutation principles has been applied to develop a method for the simultaneous analysis of two pharmaceuticals (naproxen and salicylic acid) in biological fluids. The multicommuted flow-through optosensor was based on direct native fluorescence measurements of both analgesics using a non-polar sorbent (C18 silica gel) as a solid sensing zone. The flow system was controlled by Java-written home-made software and designed using three-way solenoid valves for an independent automated manipulation of sample and carrier solutions. Using an optimized sampling time, the method was calibrated in the range of 1 - 25 and 5 - 200 ng mL(-1). The obtained detection limits were 0.3 and 1.3 ng mL(-1) for naproxen and salicylic acid, respectively, with RSD (%) values of better than 2% for both analytes. The proposed methodology was successfully applied to urine, serum and pharmaceutical preparations. Recovery percentages ranging from 96.1 to 104% were obtained for both analytes.     

Permanganate-based chemiluminescence analysis of cefadroxil monohydrate in pharmaceutical samples and biological fluids using flow injection

A chemiluminescent method using flow injection is described for the determination of cefadroxil monohydrate. The method is based on the chemiluminescence reaction of cefadroxil with potassium permanganate in sulphuric acid, sensitized by quinine. The proposed procedure allows the determination of cefadroxil over the concentration range 0.1-30 mug ml(-1) with a detection limit of 0.05 mug ml(-1) and a sample measurement frequency of 150 samples h(-1). The method was successfully applied to the determination of cefadroxil in pharmaceutical preparations and biological fluids.     

Determination of trace chromium(VI) and molybdenum(VI) in natural and bottled mineral waters using long pathlength absorbance spectroscopy (LPAS)

A flow-through solid phase spectrophotometric (SPS) sensing device is proposed for the determination of minoxidil. The analyte is concentrated on Sephadex SP-C25 ion-exchanger packed in a flow cell and it is monitored by UV-Vis spectrophotometry at 282 nm, without derivatization reaction. When a HCl (10(-2) mol l(-1))/NaCl (5x10 (-2) mol l (-1)) solution is used as carrier/desorbing solution, the sensor responds linearly in the measuring range of 0.2-7, 0.1-4 and 0.05-2 mug ml(-1) with detection limits of 60, 33 and 6 ng ml(-1) for 600, 1000 and 2000 mul of sample, respectively. The relative standard deviations (%) for these volumes are 0.38, 1.06 and 2.63, respectively. The method was satisfactorily applied to the determination of minoxidil in pharmaceutical preparations and the results were compared with those obtained by high performance liquid chromatography (HPLC).     

Fluorometric determination of 3,4-dihydroyphenylalaine in pharmaceutical formulation by reaction with paracetamol

A new method has been developed for the fluorometric determination of 3,4-dihydroxyphenylalaine (l-dopa) in pharmaceutical formulations. The reaction product, belonging to fluorescent species, has the excitation and emission maxima at 410 and 510 nm, respectively. Under the optimum conditions, responses were linear between 0.06-4.0 and 4.0-12.0 mug ml(-1). The detection limit, corresponding to a signal-to-noise ratio of 3, was 1 ng ml(-1). The relative standard deviation (n=10) was 0.6%. The proposed method was applied to determination of l-dopa in pharmaceutical formulations.     

Flow injection chemiluminescence determination of thiamine based on its enhancing effect on the luminol-hydrogen peroxide system

A new flow injection chemiluminescence (CL) method is proposed for the determination of thiamine, based upon its enhancing effect on the CL reaction of luminol with hydrogen peroxide in alkaline solution. The method allows the determination of thiamine within 0.05-8 mug ml(-1) range with a detection limit (3sigma) of 0.01 mug ml(-1). The relative standard deviation is 1.4% (n=11, 0.5 mug ml(-1) thiamine) and the sample throughput is about 90 samples h(-1). The method was successfully applied to the determination of thiamine in pharmaceutical preparations.     

Determination of clenbuterol in pharmaceutical preparations by reaction with o-phthalaldehyde using a flow-injection fluorimetric procedure

A new procedure for the determination of clenbuterol is proposed using flow-injection and fluorimetric detection. The method is based on the derivatization reaction of the primary amine group with o-phthalaldehyde in the presence of 2-mercaptoethanol. The calibration graph based on peak area was linear in the range 0.2-5 mug ml(-1) and the detection limit was 0.06 mug ml(-1). The method was validated using a reference spectrophotometric procedure and was applied to the determination of the drug in commercial pharmaceutical preparations.     

Reagentless chemiluminescence flow sensor for the determination of riboflavin in pharmaceutical preparations and human urine

A novel continuous-flow sensor based on chemiluminescence (CL) detection was developed for the determination of riboflavin at pg ml(-1) levels by the immobilization of the reagents. It was found that the CL intensity from the oxidation between luminol and periodate could be enhanced in the presence of riboflavin. The increase of CL emission was correlated with the riboflavin concentration in the range from 0.04 to 200 ng ml(-1), and the detection limit was 0.02 ng ml(-1) (3s). Considering the effective reaction ions, luminol and IO4- was immobilized on anion-exchange resin. The system could produce an evident CL signal by water as eluant and it was also shown that the flow sensor could greatly improve the selectivity and sensitivity for determination of riboflavin with a high signal-to-noise ratio. A complete analysis, including sampling and washing, could be performed in 0.5 min with a relative standard deviation of less than 3.0%. The flow sensor was applied successfully to the determination of riboflavin in pharmaceutical preparations and human urine samples.     

Flow-injection chemiluminometric analysis of some benzamides by their sensitizing effect on the cerium-sulphite reaction

A simple, highly sensitive chemiluminescent method using flow injection is described for the determination of three substituted benzamides, namely: sulpiride, sultopride and tiapride. The method is based on the sensitizing effect of these drugs on the chemiluminometric oxidation of sulphite by cerium(IV). The different experimental parameters affecting the chemiluminescence intensity were carefully studied and incorporated into the procedure. The method permits the determination of 0.05-2.5 mug ml(-1) sulpiride, 0.01-2.5 mug ml(-1) sultopride hydrochloride and 0.01-1.5 mug ml(-1) tiapride hydrochloride with minimum detectability of 0.01 mug ml(-1). The method was applied to the determination of these benzamides in pharmaceutical preparations and biological fluids.     

Spectrophotometric determination of tranexamic acid in pharmaceutical bulk and dosage forms.

In this study, a simple, fast, accurate and sensitive spectrophotometric method has been developed for the determination of tranexamic acid in bulk and pharmaceutical preparations. The method is based on the reaction of ninhydrin with the primary amino group of tranexamic acid in the basic medium at pH 8.0. The reaction produces a bluish-purple color which absorbs maximally at 565 nm. Beer's law was obeyed in the range of 3-40 microg ml(-1) with molar absorptivity of 5.093 x 10(3) L mol(-1) cm(-1). The effects of various factors such as temperature, heating time, concentration of reagent, color stability and interferences were investigated to optimize the procedure. The results have been validated analytically and statistically. The proposed method has been applied for the determination of tranexamic acid in bulk and pharmaceutical preparations with good results.     

Analysis of metformin dosage formulations by capillary electrophoresis at nano scale detection

An inexpensive, rapid and reproducible capillary electrophoretic method has been developed and validated for the determination of metformin in pharmaceutical preparations. The method was developed utilizing a fused silica capillary (60 cm x 50 microm I.D.), phosphate buffer (50 mM, 3.0 pH)-acetonitrile (95:5, v/v) as background electrolyte (BGE), 20 kV applied voltage with UV detection at 254 nm and at a working temperature of 23 +/- 1 degrees C. Linearity was observed in the concentration range from 100 ng/L to 5 microg/L, with a correlation coefficient (R2) of 0.9998. The limits of detection and quantification achieved were 60 and 100 ng/mL, respectively. The recovery of metformin from pharmaceutical preparations was 99.1%. These validation parameters demonstrate the precision of the method and its suitability for the determination of metformin in pharmaceutical tablet formulations.     

Automatic determination of cobalt at the submicrogram per millilitre level using a flowthrough spectrophotometric sensor

A flowthrough spectrophotometric sensor for the determination of cobalt at the nanogram per millilitre level using pyridoxal 4-phenylthiosemicarbazone as reagent and integrated preconcentration and detection in the flow cell is proposed. The method is highly selective for cobalt(II); it features detection and determination limits of 0.02 and 0.06 mug ml(-1) respectively, and a linear range of at least 0.04-18 mug ml(-1). The method is subject to very few interferences because the strongly acidic medium used prevents the formation of most complexes of the reagent with other metal ions. The method was applied to the determination of cobalt in pharmaceutical preparations.     

Flow-injection determination of ornidazole by chemiluminescence detection based on a luminol-ferricyanide reaction.

A flow-injection analysis (FIA) with a chemiluminescence detection method was developed for the determination of ornidazole based on the inhibition intensity of chemiluminescence from the luminol-ferricyanide system. Under the condition of 1.0 x 10(-3) mol/L luminol and 5.0 x 10(-6) mol/L potassium ferricyanide, the response to the concentration of omidazole is linear from 0.2 microg ml(-1) to 10 microg ml(-1), and a detection limit of 0.05 microg ml(-1) can be obtained. This method has been successfully applied to the determination of omidazole in pharmaceutical preparations.     

Determination of naproxen in pharmaceutical preparations by room-temperature phosphorescence. A comparative study of several organized media.

Different methods for the determination of naproxen by room-temperature phosphorescence (RTP) using organized media such as cyclodextrins (beta-CD and gamma-CD) and micelles (Triton X-100 and sodium dodecyl sulfate) are reported. The inclusion complexes formed between both beta- and gamma-cyclodextrins and naproxen were previously investigated at both acid and basic pH by spectrofluorimetry. In both cases, 1:1 guest-host stoichiometries were established and the corresponding association constants were calculated. Different systems were examined with the purpose of obtaining phosphorescent emission from naproxen solutions, and the best signals were obtained when naproxen was in the presence of beta-CD-cyclohexane-Tl(I), gamma-CD-1,3-dibromopropane, Triton X-100-Tl(I) and SDS-Tl(I), respectively. In all cases, sodium sulfite was used as deoxygenator. The use of an inorganic compound (thallium nitrate) as a heavy-atom source in a cyclodextrin system represents a novel finding. Surface response optimization approaches were carried out to optimize the chemical variables which have an influence on the RTP emission of naproxen. Based on the results obtained, univariate RTP calibration methods for the determination of the analyte in pharmaceutical preparations were satisfactorily developed. In one case, the standard additions method was applied to a mixture of naproxen and the antibiotic tetracycline.     

Flow injection spectrophotometric determination of tetracycline in a pharmaceutical preparation by complexation with aluminium(III).

A rapid flow injection (FI) spectrophotometric procedure for tetracycline determination is described. It is based on the injection of a 100 microl sample solution containing tetracycline into merged streams of aluminium(III) chloride (0.01 mol 1(-1)) and Tris-buffer in the presence of KCl (0.06 mol l(-1)), pH 7.0, with the same optimum flow rate of 3.2 ml min(-1). A yellow Al(III)-tetracycline complex was monitored at 376 nm. The flow injection system and the experimental conditions were optimized by means of the univariate method. The procedure was applied to the determination of tetracycline in pharmaceutical preparations with a high sampling rate of at least 165 h(-1). A high precision with a relative standard deviation was obtained less than 0.72 and 0.30% of 5.0 and 10 microg ml(-1) (n=11), respectively. The detection limit (3sigma) and the quantification limit (10sigma) were 0.07 and 0.72 mg l(-1), respectively. There were no interference effects from traditional excipients in the dosage forms when the method was applied to pharmaceutical preparations. The matrix effect could be reduced by the standard addition method.     

Simultaneous determination of naproxen, salicylic acid and acetylsalicylic acid by spectrofluorimetry using partial least-squares (PLS) multivariate calibration

Determination of naproxen, salicylic acid and acetylsalicylic acid has been carried out in mixtures of up to three components by recording emission fluorescence spectra between 300 and 520 nm with an excitation wavelength of 290 nm. The excitation-emission spectra of these compounds are strongly overlapped, which does not permit their direct determination without previous separation by conventional methodologies. Here, a method is proposed for the determination of these chemicals by the use of a full-spectrum multivariate calibration method, partial least-squares (PLS). The experimental calibration matrix was designed with 18 samples. The concentrations were varied between 0.1 and 1.0 mug ml(-1) for naproxen, 0.5 and 5.0 mug ml(-1) for salicylic acid and from 2.0 to 12.0 mug ml(-1) for acetylsalicylic acid. The cross-validation method was used to select the number of factors. To check the accuracy of the proposed method, the optimized model, obtained using PLS-1, was applied to the determination of these compounds in pharmaceuticals and human serum samples previously spiked with different amounts of each chemical.